Kalyan Roy: The Critical Role of Chelation Therapy in Thalassaemia
Kalyan Roy, Transfusion Medicine Specialist at Square Hospitals LTD, shared a post on LinkedIn:
“Iron Overload in Thalassaemia.
The silent threat of chronic transfusion therapy.
For patients with β-thalassaemia major, regular blood transfusion is lifesaving — but repeated transfusions gradually lead to iron overload (Transfusional Hemosiderosis).
Since the body cannot effectively remove excess iron, iron accumulates in vital organs over time.
Organs affected
Excess iron deposition commonly affects:
- Heart
- Liver
- Endocrine glands
- Pancreas
This may result in:
- Cardiomyopathy
- Arrhythmia
- Liver fibrosis and cirrhosis
- Diabetes mellitus
- Delayed puberty and hormonal dysfunction
Monitoring iron overload
Early detection is essential.
- Important investigations include:
- Serum Ferritin
- MRI T2 of Heart and Liver
- Liver Iron Concentration (LIC)
- Cardiac and Endocrine Evaluation
MRI T2 remains one of the most valuable non-invasive tools for assessing cardiac and hepatic iron burden.
Iron chelation therapy
Iron chelation is the cornerstone of management and significantly improves long-term survival.
Common Chelators:
- Deferasirox (DFX)
- Deferiprone (DFP)
- Deferoxamine (DFO)
Treatment should always be individualized based on:
- Iron burden
- Organ involvement
- Patient compliance
- Clinical response
Long-term care is essential.
Successful thalassaemia management requires:
- Regular iron monitoring
- Timely chelation adjustment
- Multidisciplinary follow-up
- Cardiac, liver and endocrine surveillance
Modern thalassaemia care focuses not only on survival — but also on preserving long-term quality of life.
Final thought
Iron overload remains one of the most important complications in chronically transfused thalassaemia patients.
Early diagnosis, appropriate chelation therapy, and continuous monitoring can dramatically reduce organ damage and improve survival.
Better transfusion support must always include better iron management.”
Stay updated with Hemostasis Today.
-
May 28, 2026, 13:42Claudio Laudani: Balancing Ischemic and Bleeding Risk in AF with Coronary Disease
-
May 28, 2026, 13:30When it Comes to Stroke Care, Quality Matters – Duke Health
-
May 28, 2026, 13:29Natalie Johnson: Transforming PE Care Through Endovascular Innovation
-
May 28, 2026, 13:16Francisco Chacón-Lozsán: Anticoagulation Strategies for Complex ICU Patients
-
May 28, 2026, 12:57Ahmed Kardousha: Protecting Growth and Fertility in Transfusion-Dependent β-Thalassemia
-
May 28, 2026, 12:36Kabilan K L: Key Nursing Considerations for Abciximab Therapy
-
May 28, 2026, 12:17Astha Thakkar: Practical Approaches to Platelet Thresholds in ITP
-
May 28, 2026, 09:16Maxime Dely: The Human Connection Behind Stem Cell Donation
-
May 28, 2026, 09:15Heghine Khachatryan: Maternal Health Begins With Recognizing Iron Deficiency Early